Ritonavir-associated hyperparathyroidism, osteopenia and bone pain

Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement.

The lancet. Diabetes & endocrinology·2025

Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024

Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer.

European thyroid journal·2023

Health-related quality-of-life analyses from a multicenter, randomized, double-blind phase 2 study of patients with differentiated thyroid cancer treated with lenvatinib 18 or 24 mg/day.

Cancer medicine·2022

Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2022

A Randomized Study of Lenvatinib 18 mg vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer.

The Journal of clinical endocrinology and metabolism·2021

Longitudinal trends in copy-years viremia associated with mpox acquisition but not mpox severity in people with HIV.

AIDS (London, England)·2026

Sex differences in long-acting cabotegravir trough concentrations in the SEARCH study in Kenya and Uganda.

AIDS (London, England)·2026

Changes in neurodevelopmental outcomes from 24 to 36 months among children HIV-exposed uninfected (CHEU) and HIV-unexposed (CHU).

AIDS (London, England)·2026

Reframing analytical treatment interruption through participants' and decliners' eyes: insights from an HIV remission trial.

AIDS (London, England)·2026

Ninety-six-week observational outcomes of long-acting injectable HIV therapy in people with adherence challenges, including people who use drugs.

AIDS (London, England)·2026

Evolving drivers of preexposure prophylaxis discontinuation among US MSM, 2018-2024.

AIDS (London, England)·2026

Comparative effects of topically applied diclofenac, ketoprofen, and piroxicam on interleukin-17, signal transducer and activator of transcription 3, and prostaglandin E2 levels in a rat model of collagen-induced arthritis.

Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina·2026

A Scoping Review of 5-HT3 Antagonist Antiemetic Medication Safety in the Management of Nausea and Vomiting of Pregnancy.

Pharmacoepidemiology and drug safety·2026

Transient teriparatide for postoperative hypocalcaemia with hungry bone features.

European journal of endocrinology·2026

Old molecule, new scrutiny: Benzoyl peroxide in dermatology.

Clinical and experimental dermatology·2026

Progranulin drives acetaminophen-induced acute liver injury by limiting hepatic recruitment of eosinophils via suppressing interleukin-33 expression.

Acta pharmaceutica Sinica. B·2026

Physician Perceptions of Particulate Versus Non-Particulate Steroids in Epidural Steroid Injections.

Orthopedic reviews·2026

Related Experiment Videos

Ritonavir-associated hyperparathyroidism, osteopenia and bone pain

Related Concept Videos

Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement.

Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers.

Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer.

Health-related quality-of-life analyses from a multicenter, randomized, double-blind phase 2 study of patients with differentiated thyroid cancer treated with lenvatinib 18 or 24 mg/day.

Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA).

A Randomized Study of Lenvatinib 18 mg vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer.

Longitudinal trends in copy-years viremia associated with mpox acquisition but not mpox severity in people with HIV.

Sex differences in long-acting cabotegravir trough concentrations in the SEARCH study in Kenya and Uganda.

Changes in neurodevelopmental outcomes from 24 to 36 months among children HIV-exposed uninfected (CHEU) and HIV-unexposed (CHU).

Reframing analytical treatment interruption through participants' and decliners' eyes: insights from an HIV remission trial.

Ninety-six-week observational outcomes of long-acting injectable HIV therapy in people with adherence challenges, including people who use drugs.

Evolving drivers of preexposure prophylaxis discontinuation among US MSM, 2018-2024.

Comparative effects of topically applied diclofenac, ketoprofen, and piroxicam on interleukin-17, signal transducer and activator of transcription 3, and prostaglandin E2 levels in a rat model of collagen-induced arthritis.

A Scoping Review of 5-HT3 Antagonist Antiemetic Medication Safety in the Management of Nausea and Vomiting of Pregnancy.

Transient teriparatide for postoperative hypocalcaemia with hungry bone features.

Old molecule, new scrutiny: Benzoyl peroxide in dermatology.

Progranulin drives acetaminophen-induced acute liver injury by limiting hepatic recruitment of eosinophils via suppressing interleukin-33 expression.

Physician Perceptions of Particulate Versus Non-Particulate Steroids in Epidural Steroid Injections.

Related Experiment Videos

Ritonavir-associated hyperparathyroidism, osteopenia and bone pain

Related Concept Videos

Related Articles